SCHEMBL16626733

SCHEMBL16626733

CNCc1cn(S(=O)(=O)c2cncc(F)c2)c2cc(Nc3ccc(OC(F)(F)F)cc3Cl)ccc12

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
P2RX7 Q99572 6/20 0.34
PPARG P37231 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
FBP1 P09467 2/20 0.33
ABL1 P00519 2/20 0.32
NAMPT P43490 1/20 0.32
EPHX2 P34913 1/20 0.31
NR1H4 Q96RI1 1/20 0.31
PIM1 P11309 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
TRPA1 O75762 1/20 0.31
RORC P51449 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16619109 0.99 HTR6 (0.34) HTR6PDE4APDE4BPDE4CPDE4D
SCHEMBL16626769 0.90 P2RX7 (0.37) HTR6P2RX7PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL16618798 0.90 P2RX7 (0.37) HTR6P2RX7PPARGPPARDPPARA
SCHEMBL16626677 0.89 NAMPT (0.39) HTR6PPARGPPARDPPARAFBP1
SCHEMBL17975927 0.89 HTR6 (0.44) HTR6PDE4APDE4BPDE4CPDE4D
SCHEMBL16626545 0.89 PDE4A (0.38) HTR6PDE4APDE4BPDE4CPDE4D
Hydrochloric Acid SCHEMBL16618820 0.89 NAMPT (0.39) HTR6PPARGPPARDPPARAFBP1
Hydrochloric Acid SCHEMBL16619048 0.88 PDE4A (0.38) HTR6PDE4APDE4BPDE4CPDE4D
SCHEMBL16626569 0.87 PDE4A (0.42) HTR6PDE4APDE4BPDE4CPDE4D
SCHEMBL16626487 0.87 HTR6 (0.39) HTR6PPARGPPARDPPARAFBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI HTR6 166/4885PDE4A 2460/4885PDE4B 1996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.